REVEAL-CKD: Prevalence and Consequences of Undiagnosed Chronic Kidney Disease
Completed
Conditions studied: Chronic Kidney Disease
In brief
This is a retrospective, multinational, non-interventional, observational study. A series of cohort studies will be conducted to assess the prevalence of undiagnosed stage 3 CKD in each region. The study will also assess the current state of CKD management in patients with undiagnosed CKD
Key facts
- Study ID
- NCT04847531
- Run by
- AstraZeneca
- People needed
- 1006361
- Starts
- 2020-12-15
- Expected to finish
- 2023-11-13
- Last updated by the study team
- 2024-12-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least two consecutive eGFR laboratory tests with values ≥30 and <60 mL/min/1.73 m2 (Stage 3A or 3B) that are >90 and ≤730 days apart. The index date is the date of the second eGFR measure meeting the criteria for stage 3 CKD
- At least 12 months of continuous presence in the database or registration in the data prior to the first qualifying eGFR (for data sources with information on enrolment)
- Age ≥18 years at index date
You may not qualify if…
- Solid organ transplant before the study index date
- Any evidence of advanced CKD (stage 4, 5) based on CKD diagnostic codes, or renal replacement therapy before the index date
Where it is running
- Research Site — Louisville, Kentucky, United States
- Research Site — Cambridge, Massachusetts, United States
- Research Site — Ann Arbor, Michigan, United States
- Research Site — Sydney, New South Wales, Australia
- Research Site — São Paulo, Brazil
- Research Site — Kingston, Ontario, Canada
- Research Site — Guangzhou, Guangdong, China
- Research Site — Boulogne-Billancourt, France
- Research Site — Frankfurt, Germany
- Research Site — Milan, Italy
- Research Site — Kyoto, Japan
- Research Site — Madrid, Spain
- Research Site — London, Greater London, United Kingdom
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.